Institutional investors purchased a net $23.7 thousand shares of HEB during the quarter ended September 2017 and now own 3.90% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TWO SIGMA SECURITIES LLC Bought 79.9 Thousand shares of Hemispherx Biopharma Inc